Eyegate Pharmaceuticals/ US30233M5031 /
2024-04-29 9:59:50 PM | Chg. - | Volume | Bid- | Ask- | High | Low |
---|---|---|---|---|---|---|
34.89USD | - | 100 Turnover: 3,489 |
-Bid Size: - | -Ask Size: - | 34.89 | 34.89 |
GlobeNewswire
2022-03-01
First Wave BioPharma Announces Appointment of Sarah Romano as Chief Financial Officer
GlobeNewswire
2021-11-08
EyeGate is Now Kiora Pharmaceuticals; Provides Update on Company’s Sharpened Clinical Development St...
GlobeNewswire
2021-10-26
EyeGate Pharmaceuticals Appoints Eric J. Daniels, MD, MBA, as Chief Development Officer and Closes A...
GlobeNewswire
2021-09-09
EyeGate to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
GlobeNewswire
2021-09-08
EyeGate Pharma Completes Target Enrollment in Phase 2 Proof-of-Concept Study to Evaluate PP-001 for ...
GlobeNewswire
2021-08-12
EyeGate Pharma Reports Second Quarter 2021 Financial Results and Provides Business Update
GlobeNewswire
2021-08-11
EyeGate Announces Closing of $10.75 Million Registered Direct Offering Priced At-The-Market Under Na...
GlobeNewswire
2021-08-10
EyeGate Announces $10.75 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
GlobeNewswire
2021-07-26
EyeGate Pharmaceuticals Announces Appointment of Brian M. Strem, Ph.D., as President and Chief Execu...
GlobeNewswire
2021-06-14
EyeGate Pharma Announces First Patient Dosed for PP-001 in a Phase 2 Proof-of-Concept Ocular Surface...
GlobeNewswire
2021-05-12
EyeGate Pharma Reports First Quarter 2021 Financial Results and Provides Business Update
GlobeNewswire
2021-04-01
EyeGate Pharma Announces the Appointment of Kenneth Gayron and Aron Shapiro to its Board of Director...
GlobeNewswire
2021-03-25
EyeGate Pharma Reports Full Year 2020 Financial Results and Provides Business Update
GlobeNewswire
2021-02-01
EyeGate Pharmaceuticals Announces Management Transition In Support of Strategic Transformation
GlobeNewswire
2019-04-19
Market Trends Toward New Normal in TAL Education Group, Invitation Home, New Gold, Eyegate Pharmaceu...
GlobeNewswire
2019-01-29
EyeGate Pharmaceuticals to Present at BIO CEO & Investor Conference in New York City
GlobeNewswire
2018-11-13
EyeGate Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Business Update
GlobeNewswire
2018-10-02
EyeGate Pharmaceuticals Signs Technology Transfer and License Agreement with SentrX Animal Care
GlobeNewswire
2018-09-25
EyeGate Pharmaceuticals Granted Additional 180 Days to Comply With Nasdaq Listing Rules
GlobeNewswire
2018-09-24
EyeGate Pharmaceuticals Completes Enrollment in Both PRK and PE Pilot Studies